Central venous catheters have become indispensable in patient care across multiple clinical areas including critical care, anesthesia, emergency medicine, and interventional radiology. These catheters offer benefits such as reliable and long-term vascular access for chemotherapy, total parenteral nutrition, blood sampling, hemodialysis, and infusion of fluids and medication. They are designed for use in peripherally inserted central catheter (PICC), peripherally inserted central catheter (PICC), non tunneled central venous catheter, and implanted ports. Tunneled and non-tunneled CVCs are commonly used during long-term treatment options for cancer and end-stage renal disease. The surging geriatric population, increasing cases of chronic diseases, and growth in the number of surgical procedures performed annually are expected to drive the demand for CVCs.
The U.S. central venous catheter market is estimated to be valued at US$ 1252.07 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in The U.S. Central Venous Catheter Market are Robert Bosch GmbH., Continental AG, DENSO CORPORATION, HELLA GmbH & Co. KGaA, Infineon Technologies AG, Autoliv Inc., Lockheed Martin Corporation., NXP Semiconductors., smart microwave sensors GmbH, Oculii Corporation, SRC, Inc., Arbe, Echodyne Corp., Raytheon Company Corporation, Saab AB, Northrop Grumman, ZF Friedrichshafen AG, Hitachi, Ltd., InnoSenT - Innovative Radar Sensor Technology, and Kestrel Radar Sensors among others. The demand for central venous catheters is growing significantly owing to rise in number of surgical procedures performed in hospitals and clinics. The increasing prevalence of chronic diseases such as cancer, end stage renal disease has also augmented the adoption of central venous catheters across the region. Moreover, increasing awareness regarding health and hygiene is encouraging the healthcare facilities adopt advanced central line catheter solutions in the region.
Market Drivers
One of the major drivers fuelling the U.S. central venous catheter market growth is the rising geriatric population. As per the United Nations report, the U.S. is home to one of the largest elderly population in the world. By 2050, it is estimated that around 89 million people (more than 20% of population) will fall into geriatric bracket. With advancing age, comes the growing risk of chronic disorders such as cardiovascular and renal diseases. This has substantially increased the demand for central venous catheters that offer long term intravenous access for comorbid conditions management. Growing prevalence of cancer cases requiring chemotherapy treatment is another primary factor boosting the need for central catheter systems. According to American Cancer Society, around 1.8 million new cancer cases are diagnosed annually in the U.S., thereby augmenting the sales opportunities for central venous catheter producers.
Impact of geopolitical situation on the growth of U.S. Central Venous Catheter Market
The unstable geopolitical situation has heightened uncertainty and disrupted global supply chains, adversely impacting various industries including the medical device sector. With growing geopolitical tensions and conflict situations worldwide, there are increasing risks of trade restrictions and protectionist policies that can affect import and export of medical devices. This can hamper the smooth flow of raw materials, components and finished products across borders for the U.S. Central Venous Catheter industry. Meanwhile, diversion of resources towards public healthcare needs in times of crisis can potentially reduce funding for non-essential medical procedures that use central venous catheters. Escalating security issues also pose risks of cyberattacks targeted at hospitals and healthcare infrastructure, disrupting operations and use of connected medical technologies. To sustain growth amid challenges, manufacturers must strategize to enhance domestic sourcing, obtain local regulatory approvals fast and develop alternative supply networks that are less vulnerable to external disruptions.
Geographical regions where the U.S. Central Venous Catheter Market is concentrated in terms of value
The U.S. central venous catheter market is highly concentrated in regions with advanced healthcare infrastructure and higher healthcare spending levels. The mature markets of North America, led by the U.S., currently account for the largest share of the global central venous catheter industry values. Within the country, major metropolitan areas like New York, Los Angeles, Chicago, Dallas and Houston dominate demand due to concentration of top-tier hospitals, medical device companies and patient population. These regions have sophisticated reimbursement systems supporting complex procedures and a growing geriatric demographic prone to chronic illnesses requiring central line placement. However, opportunities are emerging in other underpenetrated states as well with expanding health insurance coverage and new catheter manufacturing units.
Fastest growing region for the U.S. Central Venous Catheter Market
Asia Pacific region is poised to experience the fastest value growth in the U.S. central venous catheter market over the forecast period. This is attributable to factors like rapidly developing public and private healthcare sectors in emerging countries, growing medical tourism particularly in India and Thailand, rising chronic disease prevalence due to lifestyle changes and aging populations. Initiatives by governments in the Asia Pacific to augment healthcare infrastructure, enhance accessibility and increase per capita healthcare spends are also bolstering the regional market expansion. Moreover, multinational companies are making strategic investments and establishing new manufacturing facilities in Asia to cater to the increasing demands and benefit from lower costs. All these dynamics are anticipated to support strongest gains for the U.S. central venous catheter industry in Asia going forward.
Get more insights on U.S. Central Venous Catheter Market
